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Enno Mandema studied Medicine from 1939–1948 in Gron-
ingen in the Netherlands and became internist in 1954. Two 
years later, he defended his PhD thesis summa cum laude. 
In 1959, he visited professor Robert M. Kark in Chicago 
during 1 year for research on the antinuclear factor, SLE, 
and proteins. In 1960, 38 years old, he became full profes-
sor of Medicine and head of Department of Medicine in 
Groningen. Together with Bob Nienhuis, he discovered the 
anti-perinuclear factor in patients with rheumatoid arthritis 
in 1963. In 2000, almost 40 years later, this serendipitous 
discovery turned out to be the anti-CCP, a very specific 
auto-antibody in rheumatoid arthritis. In 1975, he became 
Honorary Fellow of the American College of Physicians and 
in 1979 Member of The Royal Netherlands Academy of Arts 
and Sciences. In 1986, Dr. Mandema retired and this was 
celebrated with an International Course on Amyloidosis 
in Groningen, organized by Jan Marrink and Martin van 
Rijswijk. After his retirement, he became the first President 
of the Dutch Council for Health Research until 1993 and 
advised the Dutch Government in three major reports. He 
was honored by Queen Beatrix and became Knight in the 
order of the “Nederlandse Leeuw”. Subsequently, he became 
the Queen’s Chamberlain for the Province of Groningen. In 
2009, the University Medical Center of Groningen founded 
a “Mandema stipendium”, a grant for stimulation of research 
performed by promising young physicians.
Amyloidosis research
In his thesis in 1956, Dr. Mandema focused his research on 
patients with multiple myeloma and Waldenström’s disease. 
Some of his patients suffered also from amyloidosis and he 
became fascinated by the disease. He saw great opportunities 
for clinical and biochemical research in this area. Together 
with Jan Scholten, Luuk Ruinen and Alan Cohen he orga-
nized the first International Symposium on Amyloidosis in 
Groningen in 1967. This Symposium marked the start of 
an era of international collaboration with huge progress of 
amyloidosis research leading to better understanding of the 
disease and improvement of patient care, treatment, and 
outcome. An independent scientific journal and a supportive 
society also mark the growing independence and relevance of 
this research area.
In the Netherlands, amyloidosis research started around 
1980 as reflected in the PhD theses of Erik Gruys, in Utrecht 
in 1979, and Martin van Rijswijk, in Groningen in 1981. In 
Groningen, Martin van Rijswijk, Jan Marrink, and Sijtze 
Meijer coached Sven Janssen (PhD 1985) in clinical studies 
of precursor proteins, e.g. SAA and M-proteins, histology 
(KMnO4) and immunohistochemistry, therapy (“precursor-
product” concept, DMSO), and clinimetry (cohort studies, 
kidney function, bone scintigraphy, and cardiac ultrasound). 
Subsequently, Martin van Rijswijk and Pieter Limburg 
coached Bouke Hazenberg (PhD 2007), Ingrid van Gameren 
(PhD 2009), and Johan Bijzet in clinical studies focusing on 
the role of subcutaneous fat tissue and SAP scintigraphy in 
diagnosis, clinimetry, and monitoring of therapy.
In Utrecht, Erik Gruys coached Paul Hol and Adriaan van 
Andel in veterinary studies of AA amyloidogenesis in Syr-
ian hamsters, cattle, and dogs with a focus on SAA and SAP. 
Localized AL amyloidosis was discovered in the horse. Sub-
sequently, Erik Gruys coached Theo Niewold (PhD 1990) in 
his studies of AEF in AA amyloidosis in hamsters and cattle, 
Yves Goffin (PhD 1989) in his studies of amyloid in human 
heart valves and joints, Wil Landman (PhD 1998), Bereket 
Zekarias (PhD 2003), and Narin Upgarin (PhD 2005) in their 
studies of GAGs, SAA, AA amyloid, amyloid arthropathy, 
and inflammation in chickens, and Jaime Rofina (PhD 2005) 
in his studies of cerebral Alzheimer-like amyloid in aged 
dogs.
Some spin-off was visible outside the amyloidosis area: 
Martin van Rijswijk coached Miek van Leeuwen in her studies 
of the effect of CRP and SAA on progression of rheumatoid 
arthritis and Erik Gruys coached S Alsemgeest and Mathilda 
Toussaint in their studies of CRP, SAA, and haptoglobin in 
small domestic animals.
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  Amyloid
Epilogue
Enno Mandema always enjoyed attending the amyloidosis 
symposia and the contacts with so many amyloid friends. He 
was respected broadly for his knowledge, his dedication to 
his patients, his interest in medical science, and his clear view 
and opinions. Besides, he was a good teacher and colleague. 
His sight diminished slowly in the last years, but it was amaz-
ing how he compensated for this handicap. At all amyloidosis 
symposia he remained deeply interested in the program. He 
frequently asked us relevant questions about all kinds of pre-
sentations− and it was often not easy to provide a satisfactory 
answer. In 2006, he was not able to attend the Symposium in 
Woods Hole because of illness of his beloved wife Atie. At 
the end of 2008, he asked us to contact him in the beginning 
of 2010 to learn whether he would feel well enough to visit 
Rome in April. It turned out to be different. In the night of 
27 January 2010, he passed away in his sleep at the blessed age 
of 88. We will remember him as a warm, congenial person and 
a good amyloid friend.
Bouke P. Hazenberg, Groningen
Erik Gruys, Utrecht
Martin H. van Rijswijk. Groningen
Figure 1. Enno Mandema together with his wife Atie in their garden 
in 1986. 
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